Harpal Dhillon is a pharmacist, founder of AntiBx and a Global Medical Value consultant.

Harpal has amassed over 15 years of experience working across healthcare, public health, academia and the pharmaceutical industry in a variety of roles within infectious diseases.

He has specialized in developing innovative strategies and initiatives to optimize antibiotic prescribing. This has included the launch of TARGET antibiotics in the UK and the execution of an EU-wide compassionate use programme for an antibiotic. His experience led to his participation in DRIVE-AB to devise global antibiotic valuation as well as his role as inaugural Chair of the Royal Pharmaceutical Society’s AMR Expert Group.

Harpal holds a PhD in strategies to optimize antibiotic prescribing from Aston University.